What inspired this Wish List Request?
To develop and integrate a qualification validation suite into JMP, based on the feedback from our pharmaceutical customers in India and the APxJ region. This enhancement is identified as a key requirement for facilitating regulatory submissions and was strongly emphasized during consultations with major clients such as Biocon, Cytel, Viatris, Lupin, and Dr. Reddy’s. This suite aims to address a universal need across various jurisdictions, thereby serving regulated pharmaceutical markets worldwide. The implementation of this feature is essential for adhering to the stringent compliance standards required in these industries globally, enhancing our product’s utility and compliance efficacy.
Please describe the new or improved feature or solution you would like to see.
We propose the development of a new qualification validation suite for JMP, designed to streamline the validation process significantly. This suite would include Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) modules, each capable of generating comprehensive, traceable, and compliant reports crucial for regulatory submissions. Emphasizing ease of integration with existing JMP workflows, this suite would automate validation, allowing test results to be obtained rapidly and reliably, reducing the validation process. This solution would support a broad spectrum of tests, providing documentation of activities through automatically generated validation reports. The validation suite would ensure compliance with global regulatory standards, including those set by the USFDA, ICH EudraLex, and the emerging requirements of ICH E6 Good Clinical Practice (GCP) R2. This strategic enhancement will enable pharmaceutical companies to confidently utilize JMP for critical regulatory submissions, thereby expanding its market applicability and strengthening its competitive position.
What would the value be to you and/or other users if this new feature is provided?
Implementing this feature would substantially increase JMP's attractiveness and utility in regulatory environments, potentially increasing license sales significantly (estimated 600-800 licenses across four customers). It would ensure that JMP meets the rigorous standards required for submission to regulatory bodies like the USFDA, ICH and EMA, thereby enhancing customer trust and satisfaction.
Is this an external customer request?
Yes, this is directly based on the needs and feedback of external customers, as evidenced by our interactions with several key pharmaceutical companies in India and APxJ.
Is there a competitive software package that has this feature or solution that we should be aware of?
Competitors like Minitab, Phoenix WinNonlin (example attached), Slim Stat, and ASAP Prime currently offer similar qualification suites, which are favored by firms for regulatory submissions. Our lack of this capability is noted as a disadvantage in the market by our users.
Will this impact a renewal, expansion, or adoption at a customer, and does this put an account at risk if we do not address this?
Yes, the absence of this feature has already impacted our sales and could hinder future renewals and expansions. Not addressing this need puts us at risk of losing potential sales to competitors, particularly impacting our market share and customer retention in the pharmaceutical sector.